COVID-19 & CancerFreeGuest Editorial The pandemic of COVID-19 and its effect on clinical trials in the communityHow do we move forward? May 01, 2020Vol.46 No.18By James N. Atkins
COVID-19 & CancerFreeGuest Editorial Under the onslaughts of COVID-19, Montefiore deployed a PPE strategy for patients—PREVENT/PROTECT/ENABLE May 01, 2020Vol.46 No.18By Balazs Halmos, Roman Perez-Soler, Stuart Packer, Mary G. LaRocca, Bruce Rapkin, Shalom Kalnicki and Joseph Sparano
Conversation with The Cancer LetterCOVID-19 & CancerFree With 61,000 people registered, first-ever virtual AACR annual meeting “enthusiastically received” May 01, 2020Vol.46 No.18By Alexandria Carolan
COVID-19 & CancerFree Remdesivir established as standard of care for COVID-19, Fauci declaresFDA issues Emergency Use Authorization May 01, 2020Vol.46 No.18By Matthew Bin Han Ong and Paul Goldberg
COVID-19 & CancerFree AACR data from China and Europe amount to “two different messages” for cancer patients with COVID-19 May 01, 2020Vol.46 No.18By Alexandria Carolan
Conversation with The Cancer LetterCOVID-19 & CancerFree Skip Burris: These few months are going to shape health care in the coming years May 01, 2020Vol.46 No.18By Paul Goldberg
Conversation with The Cancer LetterCOVID-19 & CancerFree NSCLC patients getting checkpoint inhibitors more likely to develop pneumonitis, Syapse-FDA-Aurora study finds May 01, 2020Vol.46 No.18By Matthew Bin Han Ong
COVID-19 & CancerFree COVID-19 vs. community oncology: Flatiron’s data provides first damage assessment May 01, 2020Vol.46 No.18By Matthew Bin Han Ong
Conversation with The Cancer LetterCOVID-19 & CancerFree Tulane Cancer Center chips away at the “digital divide” that keeps the underserved from benefiting from telemedicine April 24, 2020Vol.46 No.17By Alexandria Carolan
Conversation with The Cancer LetterCOVID-19 & CancerFree Feist-Weiller mammography vans repurposed to screen for COVID-19 in northwest Louisiana April 24, 2020Vol.46 No.17By Alexandria Carolan
